All About

HEOR | RWE

Get a detailed vision of our HEOR, Real World Data  & Real-World Evidence ​solutions and offerings. 

Refine the healthcare outcomes with Real World Evidence (RWE) and Real-World Data (RWD) using health economics and outcomes research (HEOR). This model assists you in making educated decisions and answering clinical questions.

At KMK, with our years of expertise and advanced techniques, we formulate a complete structure, including real-world studies to showcase the drug efficacy and its value in the marketplace to varied stakeholders. 

To get in-depth insight, explore our customer success stories and get an insight into how we assisted helped pharmaceutical companies achieve commercial goals. It is also KMK’s best thinking, expertise, and client results.

Case Studies

White Paper

Webinars

Publications

Our latest

Case Studies

Let's Talk

WE LOVE
TO HEAR

KMK’s best thinking, expertise, and client results on pharmaceutical commercial operations, sales analytics, data management, market research, and sales force effectiveness.

Our latest

White Papers

Let's Talk

WE LOVE
TO HEAR

KMK’s best thinking, expertise, and client results on pharmaceutical commercial operations, sales analytics, data management, market research, and sales force effectiveness.

Our latest

Let's Talk

WE LOVE
TO HEAR

KMK’s best thinking, expertise, and client results on pharmaceutical commercial operations, sales analytics, data management, market research, and sales force effectiveness.

Our latest

Let's Talk

WE LOVE
TO HEAR

KMK’s best thinking, expertise, and client results on pharmaceutical commercial operations, sales analytics, data management, market research, and sales force effectiveness.

Migraine

Neurology: Clinical Practice

Unmet Need in the Market Economic Burden Increased with Number of Treatment Failures in Migraine Patients – A Retrospective Claims Database Analysis in the United States

KMK Participants : Lujia Zhou

Psoriatic arthritis

Springer-Drugs-Real World Outcomes

Association Between Treatment Patterns and Healthcare Utilization Healthcare Cost and Utilization Associated With Biologic Treatment Patterns Among Patients With Psoriatic Arthritis: Analyses From a Large US Claims Database

KMK Participants : Piao OW, Zheng JZ

Rheumatoid Arthritis

Rheumatology and Therapy

Understanding Real-world Patient Profiles & Identifying Primary Product Benefactor Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis

KMK Participant : Fahim M

lymphoma

Real-World Treatment Patterns

Real-World Treatment Patterns among Patients with Mycosis Fungoides and Sézary Syndrome in the United States between 2018 and 2020

KMK Participant : Huanxue Z.

Multiple Sclerosis

International Journal of MS Care

Impact of switching to fingolimod versus injectable disease-modifying therapy cycling on risk of multiple sclerosis-related relapses: A retrospective analysis

KMK Participants : Huanxue Zhou, Olivia Wenxian Piao 

Ankylosing spondylitis

Journal of Managed Care Specialty Pharmacy

Healthcare Utilization and Cost Associated With Switching Biologics Within the First Year of Biologic Treatment Initiation Among Patients With Ankylosing Spondylitis

KMK Participants : Piao OW, Zheng JZ

Multiple Sclerosis

Advances in Therapy

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

KMK Participants : Huanxue Zhou

Migraine

The Journal of Headache and Pain

Real-world Product Value Demonstration Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

KMK Participants :Shen Y, Zhou L

Multiple Sclerosis

International Journal of MS Care

Utilization and Treatment Patterns of Disease-Modifying Therapy Among Pediatric Patients With Multiple Sclerosis in the United States

KMK Participants : Mengru Wang

Follicular Lymphoma

JHEOR

Treatment patterns and health care costs in commercially insured patients with follicular lymphoma

KMK Participants : Chen G